免疫調節剤の世界市場分析:製品別(免疫抑制剤、免疫刺激剤、ワクチン、抗体)、用途別(腫瘍学、呼吸器、HIV)、地域別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region-based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Immunomodulators Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing adoption of monoclonal antibodies
3.1.1.2 Rising incidence of cancer and other chronic conditions
3.1.1.3 Presence of strong pipeline portfolio
3.1.2 Market Restraint Analysis
3.1.2.1 High number of patent expiration
3.1.2.2 Growing generic & biosimilars competition
3.2 Penetration & Growth Prospect Mapping
3.3 Immunomodulators – PESTLE Analysis
3.4 Industry Analysis – Porter’s
Chapter 4 Immunomodulators Product Estimates & Trend Analysis
4.1 Immunomodulators Market: Product Movement Analysis
4.2 Immunosuppressants
4.2.1 Immunosuppressants market, 2014 – 2025 (USD Billion)
4.2.2 Antibodies
4.2.2.1 Antibodies market, 2014 – 2025 (USD Billion)
4.2.3 Calcineurin inhibitors
4.2.3.1 Calcineurin inhibitors market, 2014 – 2025 (USD Billion)
4.2.4 Glucocorticoid
4.2.4.1 Antimetabolites market, 2014 – 2025 (USD Billion)
4.2.5 Antimetabolites
4.2.5.1 Antimetabolites market, 2014 – 2025 (USD Billion)
4.2.6 Others
4.2.6.1 Others market, 2014 – 2025 (USD Billion)
4.3 Immunostimulants
4.3.1 Immunostimulants market, 2014 – 2025 (USD Billion)
4.3.2 Vaccines
4.3.2.1 Vaccines market, 2014 – 2025 (USD Billion)
4.3.3 Antibodies
4.3.3.1 Antibodies market, 2014 – 2025 (USD Billion)
4.3.4 Others
4.3.4.1 Others market, 2014 – 2025 (USD Billion)
Chapter 5 Immunomodulators Application Estimates & Trend Analysis
5.1 Immunomodulators Market: Application Movement Analysis
5.2 Oncology
5.2.1 Oncology s market, 2014 – 2025 (USD Billion)
5.3 Respiratory
5.3.1 Respiratory market, 2014 – 2025 (USD Billion)
5.4 HIV
5.4.1 HIV market, 2014 – 2025 (USD Billion)
5.5 Others
5.5.1 Others market, 2014 – 2025 (USD Billion)
Chapter 6 Immunomodulators Regional Estimates & Trend Analysis, by Product and Applications
6.1 Immunomodulators market share by region, 2015 & 2024
6.2 North America
6.2.1 North America immunomodulators market, 2014 – 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. immunomodulators market, 2014 – 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada Immunomodulators market, 2014 – 2025 (USD Billion)
6.3 Europe
6.3.1 Europe Immunomodulators market, 2014 – 2025 (USD Billion)
6.3.2 UK
6.3.2.1 UK Immunomodulators market, 2014 – 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Germany Immunomodulators market, 2014 – 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Immunomodulators market, 2014 – 2025 (USD Billion)
6.4.2 Japan
6.4.2.1 Japan Immunomodulators market, 2014 – 2025 (USD Billion)
6.4.3 China
6.4.3.1 China Immunomodulators market, 2014 – 2025 (USD Billion)
6.4.4 India
6.4.4.1 India Immunomodulators market, 2014 – 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America Immunomodulators market, 2014 – 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil Immunomodulators market, 2014 – 2025 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico Immunomodulators market, 2014 – 2025 (USD Billion)
6.6 MEA
6.6.1 MEA Immunomodulators market, 2014 – 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa Immunomodulators market, 2014 – 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Amgen, Inc.
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Abbott
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 ProductBenchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Johnson & Johnson
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Novartis AG
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Eli Lilly and Company
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Bristol-Myers Squibb Company
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Merck & Co., Inc.
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Biogen
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:免疫調節剤の世界市場分析:製品別(免疫抑制剤、免疫刺激剤、ワクチン、抗体)、用途別(腫瘍学、呼吸器、HIV)、地域別、セグメント予測、2014-2025
■ 英文:Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014-2025
■ 発行日:2016年12月7日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707423
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。